The combination of CJC-1295 and Ipamorelin is a synergistic peptide therapy designed to stimulate the body’s natural production of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). CJC-1295 is a growth hormone-releasing hormone (GHRH) analog with a long half-life, while Ipamorelin is a selective growth hormone-releasing peptide (GHRP) known for its clean hormonal profile, avoiding unwanted spikes in cortisol or prolactin. Together, they enhance fat metabolism, tissue repair, muscle recovery, and overall cellular regeneration.
